- Research article
- Open Access
The Vibrio parahaemolyticus Type III Secretion Systems manipulate host cell MAPK for critical steps in pathogenesis
BMC Microbiology volume 10, Article number: 329 (2010)
Vibrio parahaemolyticus is a food-borne pathogen causing inflammation of the gastrointestinal epithelium. Pathogenic strains of this bacterium possess two Type III Secretion Systems (TTSS) that deliver effector proteins into host cells. In order to better understand human host cell responses to V. parahaemolyticus, the modulation of Mitogen Activated Protein Kinase (MAPK) activation in epithelial cells by an O3:K6 clinical isolate, RIMD2210633, was investigated. The importance of MAPK activation for the ability of the bacterium to be cytotoxic and to induce secretion of Interleukin-8 (IL-8) was determined.
V. parahaemolyticus deployed its TTSS1 to induce activation of the JNK, p38 and ERK MAPK in human epithelial cells. VP1680 was identified as the TTSS1 effector protein responsible for MAPK activation in Caco-2 cells and the activation of JNK and ERK by this protein was important in induction of host cell death. V. parahaemolyticus actively induced IL-8 secretion in a response mediated by TTSS1. A role for VP1680 and for the ERK signalling pathway in the stimulation of IL-8 production in epithelial cells by V. parahaemolyticus was established. Interestingly, TTSS2 inhibited IL-8 mRNA transcription at early stages of interaction between the bacterium and the cell.
This study demonstrated that V. parahaemolyticus activates the three major MAPK signalling pathways in intestinal epithelial cells in a TTSS1-dependent manner that involves the TTSS1 effector VP1680. Furthermore VP1680 and JNK and ERK activation were needed for maximal cytotoxicity of the bacterium. It was shown that V. parahaemolyticus is a strong inducer of IL-8 secretion and that induction reflects a balance between the effects of TTSS1 and TTSS2. Increases in IL-8 secretion were mediated by TTSS1 and VP1680, and augmented by ERK activation. These results shed light on the mechanisms of bacterial pathogenesis mediated by TTSS and suggest significant roles for MAPK signalling during infection with V. parahaemolyticus.
Vibrio parahaemolyticus is a gram negative, halophilic bacterium that is found in warm marine environments, such as the commensal microflora of shellfish [1, 2]. The bacterium is a major food-borne pathogen that causes acute gastroenteritis following consumption of undercooked or raw shellfish, especially oysters. It has become an increasingly important pathogen during the last decade as pandemic strains have emerged, most likely due to rising global temperatures and increased seafood consumption . Approximately 50% of all cases of food-borne gastroenteritis in Southeast Asia are due to V. parahaemolyticus. It is one of the major health and economic problems in this region and the incidence of infection is rising throughout the United States, South America and Europe [4–8]. The bacterium infects the human intestinal epithelium causing diarrhoea, intestinal inflammation, abdominal cramps, nausea, vomiting, headaches, fever, chills and in some cases even death [8, 9]. Intestinal epithelial responses to V. parahaemolyticus infection include the activation of the inflammatory cascade, infiltration of phagocytes, epithelial cell damage, alterations in the structure and function of the tight junction barrier and the induction of fluid and electrolyte secretion [10, 11].
Sequencing of the genome of a pandemic strain of V. parahaemolyticus (RIMD2210633) in 2003 revealed the presence of two sets of genes encoding two separate Type III Secretion Systems, named TTSS1 and TTSS2 . TTSS1 is present in all V. parahaemolyticus strains and is involved in host cell cytotoxicity, while TTSS2 is responsible for enterotoxicity (the ability to induce fluid accumulation in the intestine) and is predominantly found in pathogenic strains [13–15]. More recently a third TTSS, that is closely related to TTSS2, was identified in trh-positive pathogenic strains of V. parahaemolyticus. TTSS effector proteins are injected from the cytosol of bacterium directly into the cytoplasm of the host cell by means of a syringe-like delivery apparatus . Once inside the host cells the effector proteins modify the activity of eukaryotic cell signalling pathways leading to changes in host cell behaviour that favour the colonization and persistence of bacteria in the host .
The Mitogen Activated Protein Kinases (MAPK) are a group of protein serine/threonine kinases that are activated in mammalian cells in response to a variety of extracellular stimuli and mediate signal transduction from the cell surface to the nucleus where they can alter the phosphorylation status of specific transcription factors [19–21]. Three major types of MAPK pathways have been reported so far in mammalian cells [19–21]. The ERK1/2 pathway is involved in cell proliferation and differentiation, whereas the JNK and p38 pathways are activated in response to stress stimuli [19–21]. The balance between factors activated by ERK, JNK and p38 determines whether the cell lives or dies [19–21]. Modification of MAPK signalling pathways by bacteria may contribute to induction of host cell death, which is an important feature of bacterial pathogenesis promoting bacterial tissue colonisation [17, 22–24]. V. parahaemolyticus induces cell death via TTSS1 in epithelial cells and macrophages [14, 25–28]. Most recently autophagic cell death has been implicated as the mechanism by which V. parahaemolyticus exerts its cytotoxicity [26, 29]. The role of MAPK in the induction of autophagy and cell death by V. parahaemolyticus has not hitherto been investigated.
The V. parahaemolyticus VopP TTSS2 effector (also known as VopA) has been shown to inhibit MAPK signalling pathways in macrophages. It binds directly to MAPK kinases (MKK), the upstream kinases that phosphorylate the MAPK, and both prevents their activation and inhibits their activity. This it accomplishes by acetylating the catalytic loop of MKK, thereby inhibiting ATP binding [18, 30]. Enteric pathogenic bacteria can elicit or suppress expression of cytokines and chemokines from host cells, often via modification of MAPK signalling pathways. Interleukin 8 (IL-8) is a chemokine secreted basolaterally by epithelial cells thus creating an IL-8 gradient responsible for migration of neutrophils to the site of infection and is a key player in the initiation of an inflammatory response. The MAPK are involved in the signal transduction pathways leading to IL-8 chemokine production [31–33]. To date there are no published data on the effect of V. parahaemolyticus infection on IL-8 expression.
Employing an in vitro model of intestinal epithelial infection we have found that V. parahaemolyticus induces JNK, ERK and p38 activation in human epithelial cells and that the TTSS1 effector VP1680 mediates the activation of p38 and JNK. Moreover, the MAPK activation within the host cells is associated with the cytotoxic effects exerted by V. parahaemolyticus and with the induction of IL-8 secretion by the bacterium. The diverse roles of MAPK signalling during infection with V. parahaemolyticus indicate that the bacterium may use more than one mechanism to sabotage normal cellular processes and disrupt host response to infection.
V. parahaemolyticus activates the MAPK signalling pathways in intestinal epithelial cells
For several pathogenic bacteria modulation of the activity of the MAPK signalling pathway is a critical event in their ability to colonise the host [22–24]. The role of MAPK signalling during V. parahaemolyticus infection and the ability of the bacteria to modulate host cell responses via this pathway has not been elucidated so far. The first aim of our study was to examine responses of cell signalling MAPK to V. parahaemolyticus. Caco-2 cells were co-incubated with WT RIMD2210633 bacteria for 15, 60 and 120 min at an MOI of 10. Anisomycin was used as a positive control to induce phosphorylation of each of the MAPK. Heat-killed (60°C, 20 min) WT bacteria were included to investigate the effect of bacterial cell surface moieties on MAPK activation, in the absence of active protein synthesis and growth. The extracted proteins were subjected to immunoblotting analysis with anti-phospho-JNK, -phospho-p38 and -phospho-ERK1/2 antibodies. The stripped membranes were re-probed with anti-total-JNK, -p38, -ERK1/2 antibody to detect the total level of each MAPK protein present in the samples and to control for loading quantities. JNK and p38 were phosphorylated in cells co-incubated with the WT bacteria, in comparison to samples obtained from untreated Caco-2 cells which showed no MAPK activation (Figure 1). Strong activation of JNK and p38 was observed at the 2 h time point, but not at earlier time points. In contrast, little or no phosphorylation of JNK and p38 was detected in cells incubated for 2 h with the heat-killed WT bacteria, indicating that the induction of activation of these two MAPK is an active process of V. parahaemolyticus requiring viable bacteria. The patterns of ERK activation in response to V. parahaemolyticus were similar with lower phosphorylation signals detected. These studies indicate that V. parahaemolyticus induces activation of the JNK, p38 and ERK MAPK signalling pathways via a mechanism requiring metabolically active bacteria.
TTSS1 of V. parahaemolyticus is responsible for activation of JNK, p38 and ERK in epithelial cells
TTSS effectors of several pathogenic bacteria have been shown to modify MAPK activation levels in eukaryotic cells [24, 34–36]. As V. parahaemolyticus was able to induce phosphorylation of p38, JNK and ERK MAPK by an active process, we next investigated the involvement of the TTSS of V. parahaemolyticus in the activation of these MAPK. Bacteria lacking a functional TTSS1 or a functional TTSS2 were constructed by deleting the corresponding vscN gene for each secretion system. Based on homology to other TTSS the vscN genes are presumed to encode the ATPases that power the secretion process. Caco-2 cells were co-incubated with WT, ΔvscN1 and ΔvscN2 V. parahaemolyticus for 2 h and MAPK activation analysed by immunoblotting. ΔvscN2 bacteria induced similar levels of JNK phosphorylation in Caco-2 cells as those induced by the WT bacteria, when compared to untreated Caco-2 cells (Figure 2). In contrast the ΔvscN1 bacteria did not cause an increase in JNK activation, indicating that TTSS1 is required for the induction of JNK phosphorylation in epithelial cells by V. parahaemolyticus. Similarly, p38 was phosphorylated to equivalent levels in cells co-incubated with WT and ΔvscN2 bacteria compared to cells alone. Activation of p38 was greatly diminished when the Caco-2 cells were incubated with ΔvscN1 bacteria showing that the TTSS1 of V. parahaemolyticus plays an essential role in the activation of p38 in epithelial cells in response to infection. Conversely TTSS2 is not required for p38 or JNK activation by V. parahaemolyticus. The degree of ERK phosphorylation was similar in cells co-incubated with wild-type, ΔvscN1 and ΔvscN2 bacteria (Figure 2), although in each case the increase compared to cells alone was less than two-fold. As the increase in activation of ERK in Caco-2 cells was low, the ability of V. parahaemolyticus to induce MAPK activation in an alternative human epithelial cell line - HeLa - was investigated. There was a greater increase in the activation of ERK in response to WT bacteria in this cell line as compared to Caco-2 cells (Figure 2). The requirement for TTSS1 to activate each MAPK was evidenced by the lack of activation seen in response to the ΔvscN1 strain. These results provide the first evidence that activation of the JNK, p38 and ERK MAPK pathways in human epithelial cells infected with V. parahaemolyticus depends on the bacterium's TTSS1.
The TTSS1-dependent cytotoxicity of V. parahaemolyticus succeeds MAPK activation
It is well known that MAPK are activated during cellular stress responses and that they mediate signal transduction events leading to cell death. It has previously been demonstrated that V. parahaemolyticus induces cell death in a TTSS1-dependent manner in a variety of cell types, including Caco-2 cells. To determine whether MAPK activation in the Caco-2 cells is a consequence of the cytotoxicity of V. parahaemolyticus we investigated the kinetics of cytotoxicity of the bacterium in these epithelial cells. The Caco-2 monolayers were co-incubated with WT, ΔvscN1 and ΔvscN2 bacteria for 1, 2, 3 or 4 h and cytotoxicity was quantified by measurement of cell lysis (LDH assays) and cellular metabolism/viability (MTT assays). After 1 and 2 h of incubation there was no significant LDH release (Figure 3A) or decrease in cell viability (Figure 3B) observed in any of the samples. Following 3 h of incubation, WT and ΔvscN2 V. parahaemolyticus induced cell lysis and decreased cell viability of the Caco-2 cells in comparison to untreated cells. A dramatic increase in cell lysis and decrease in cell viability was observed in the Caco-2 cells co-incubated with the WT and ΔvscN2 bacteria at the 4 h time point, with more than 80% cell death. In contrast, no significant cell death was detected in samples co-incubated with the ΔvscN1 V. parahaemolyticus or with heat-killed WT bacteria at any time point and the levels obtained were comparable to the results obtained for untreated Caco-2 cells. Overall the results confirmed that TTSS1 is required for the cytotoxicity of V. parahaemolyticus towards Caco-2 cells. The LDH and MTT assay results mirrored one another, notwithstanding that MTT measures changes in cell metabolism and as such is a more sensitive reflection of cell pathology than membrane damage. Moreover, we have shown that V. parahaemolyticus was cytotoxic to the epithelial cells in a time-dependent manner with no cell lysis occurring at the 2 h time point and increasing amounts of cell lysis at the later 3 h and 4 h time points.
These results prompted us to determine Caco-2 cell viability using fluorochrome staining (Figure 3C). Caco-2 cells co-incubated with WT, ΔvscN1 and ΔvscN2 bacteria were stained with Hoechst 33324 to visualize cell nuclei. Propidium iodide was included in the study to visualise dead cells that incorporate the stain due to loss of their membrane integrity. The results revealed that WT V. parahaemolyticus and the TTSS deletion mutants did not affect the viability of the Caco-2 cells during the first 2 h of co-incubation. The cytotoxic effect of V. parahaemolyticus infection was observed after 4 h of incubation of the Caco-2 cells with WT and ΔvscN2, but not ΔvscN1, bacteria confirming that V. parahaemolyticus cytotoxicity is TTSS1-dependent.
Next we examined the morphological changes induced in epithelial cells by V. parahaemolyticus. Figure 3D shows the development of rounded cells after 2 h of co-incubation of the Caco-2 cells with the WT bacteria. After 4 h the rounded cells were still present but visible cell loss was also observed because of the cytotoxic effect exerted by V. parahaemolyticus, consistent with the LDH and MTT results. Similar to WT bacteria, the ΔvscN2 mutant induced cell rounding after 2 h of co-incubation and cell rounding combined with significant cell loss after 4 h. The monolayer of Caco-2 cells co-incubated with ΔvscN1 bacteria remained intact and exhibited the morphological features of untreated cells, even after 4 h of co-incubation, suggesting that TTSS1 is required for monolayer disruption and cell rounding and confirming its role in the cytotoxicity of V. parahaemolyticus towards epithelial cells.
Together these results suggest that the cytotoxicity of V. parahaemolyticus is TTSS1-dependent and show that this cytotoxic effect occurs after 3 h of co-incubation. As strong MAPK activation is observed after 2 h of co-incubation, we propose that MAPK activation is not a consequence of cytotoxicity, but rather it might be a prerequisite for cytotoxicity.
JNK and ERK are involved in the TTSS1-dependent cytotoxicity of V. parahaemolyticus
As MAPK signalling pathways are involved in cell fate determination by co-ordinately regulating a wide range of cellular activities ranging from gene expression, metabolism and motility to mitosis, survival, differentiation and apoptosis , we next sought to determine whether the cytotoxicity of V. parahaemolyticus was a result of MAPK activation by the use of MAPK inhibitors. SP600125 is a reversible ATP-competitive inhibitor of JNK that prevents the phosphorylation of JNK substrates. In an analogous manner SB203580 is a specific inhibitor of p38 by acting as a competitive inhibitor of ATP binding. PD98059 is a selective inhibitor of MEK1 activation and the ERK cascade, as it binds to the inactive forms of MEK1 and prevents activation by upstream activators. The concentration of inhibitors that abrogated MAPK activity was initially determined by titration experiments with 7-day Caco-2 cells stimulated with anisomycin. The activation levels of ERK, the p38 target MK-2 and the JNK target c-jun in cell lysates were assessed by immunoblotting with phospho-specific antibodies. Each MAPK inhibitor specifically reduced the phosphorylation of its cognate indicator protein (data not shown). To assess the importance of MAPK activation in the cytotoxic ability of V. parahaemolyticus, WT bacteria were co-incubated with Caco-2 cells in the presence of SB203580, SP600125 or PD98059 for 4 h and then the LDH assay was performed to quantify the level of cell lysis. The inhibitors alone did not affect the viability of the Caco-2 cells (data not shown). The JNK and ERK inhibitors (SP600125 and PD98059, respectively) caused a decrease in Vibrio-induced cell lysis of the Caco-2 cells. Cytotoxicity was reduced by about a third by each of these inhibitors (Figure 4A). In contrast, there was no significant difference in the level of cell lysis that occurred in samples incubated with or without the p38 inhibitor (SB203580). Addition of both SP600125 and PD98059 together during the co-incubation did not decrease cytotoxicity levels below the level seen with either inhibitor alone (data not shown). The results suggest that activation of JNK and ERK, but not p38, is involved in the ability of V. parahaemolyticus to be cytotoxic to the Caco-2 cells. Recently autophagic cell death has been implicated as the mode of TTSS1-mediated cytotoxicity [25, 29]. The effect of the MAPK inhibitors on the induction of this process by WT V. parahaemolyticus was assessed by visualising monodansylcadaverine (MDC) accumulation in autophagic vacuoles. Increased MDC accumulation occurred upon co-incubation with WT bacteria (Figure 4B) and this accumulation was less evident in the presence of the ERK inhibitor PD98059. These results indicate that activation of ERK by V. parahaemolyticus may influence cytotoxicity at the stage of autophagy induction, while JNK may act at a later stage.
The TTSS1 effector VP1680 regulates MAPK activation
The results above demonstrated that TTSS1 was responsible for stimulating the activation of p38 and JNK in epithelial cells in response to V. parahaemolyticus. Three proteins have so far been identified as TTSS1 effector proteins, namely VP1680 (also known as VopQ and VepA), VP1686 (also known as VopS) and VPA0450 and of these three proteins VP1680 has been implicated in the ability of V. parahaemolyticus to be cytotoxic to epithelial cells [25, 29]. As we had shown a link between the two TTSS1-dependent activities of cytotoxicity and MAPK activation, the role of VP1680 in these processes was next investigated. First a strain of V. parahaemolyticus containing a knock-out of the vp1680 gene was constructed. To authenticate the mutation, the level of cell lysis induced by the Δvp1680 strain was determined by the LDH assay. Over a 4 h period the viability of the Caco-2 cells co-incubated with the Δvp1680 strain was comparable to the viability of cells co-incubated with the ΔvscN1 strain (at the 4 h time point the percentage cell lysis values were: WT - 52±8%; ΔvscN1 - 10±2%; Δvp1680 -8±1%) confirming that the VP1680 TTSS1 effector protein is the principle factor responsible for the cytotoxicity of V. parahaemolyticus towards epithelial cells. Analysis of the morphology of the cells co-incubated with the Δvp1680 bacteria showed that the cells were still attached to the substratum as a confluent monolayer, but appeared rounded and did not display evidence of tight junctions (Additional file 1, Figure S1). In contrast cells co-incubated with ΔvscN1 bacteria were indistinguishable from non-infected cells. This indicated that VP1686 [37, 38] was being the translocated into host cells by Δvp1680 bacteria and that TTSS1 was functional in this strain.
Analysis of the ability of this Δvp1680 strain to induce MAPK activation in the Caco-2 and HeLa cells was performed by immunoblotting of the extracted proteins with anti-phospho-JNK, -p38 and -ERK antibodies (Figure 2). In Caco-2 cells, the Δvp1680 strain lacked the ability to activate p38 and JNK to the extent seen with the WT, indicating that VP1680 was the TTSS1 effector required for activation of these two MAPK. While reduced ERK activation was observed with the Δvp1680 strain as compared to the WT, a conclusive resolution could not be drawn, due to the low overall fold increase in ERK activation. In HeLa cells a more pronounced decreased phosphorylation of ERK occurred in response to Δvp1680. In contrast, VP1680 was only partly responsible for activation of p38 and JNK, as just a slight reduction in phosphorylation was seen in cells co-incubated with the V. parahaemolyticus strain lacking this effector as compared to WT bacteria. As activation of the MAPK is not abolished when VP1680 is non-functional, this suggests that there is an alternative TTSS1 effector that can activate MAPK in HeLa cells, but not in Caco-2 cells
Our results show that VP1680 is necessary for the activation of JNK and p38 in Caco-2 cells and that JNK is involved in the VP1680-dependent cytotoxicity of V. parahaemolyticus. These data together demonstrate that VP1680 is required for the ability of V. parahaemolyticus to be cytotoxic to epithelial cells, at least in part through activation of JNK.
Both TTSS are involved in modulation of IL-8 secretion by intestinal epithelial cells in response to V. parahaemolyticus
In response to pathogenic bacteria, intestinal epithelial cells produce a number of pro-inflammatory cytokines and chemokines, such as IL-8 which attracts neutrophils to the site of infection and can lead to inflammatory responses that may facilitate bacterial infection and colonisation [39–41]. The MAPK are key players in the signal transduction pathways that lead to IL-8 secretion. Therefore we tested the ability of V. parahaemolyticus to induce IL-8 secretion from Caco-2 cells and investigated the role of the TTSS and the MAPK in this event. The V. parahaemolyticus strains carrying mutations in each of the two TTSS were co-incubated with Caco-2 cells and the IL-8 response was measured by RT-PCR and ELISA (Figure 5A and 5C respectively). IL-1β was added as a positive control for the induction of IL-8 secretion. RNA extracts were prepared after 2 h of co-incubation while the supernatant used for ELISA detection of IL-8 was recovered 24 h later.
The RT-PCR results showed that IL-8 transcription was strongly activated by the IL-1β positive control and was induced to a lower extent by WT V. parahaemolyticus, while there was no increase of transcription observed using the heat-killed V. parahaemolyticus (Figure 5A). This result shows that live V. parahaemolyticus actively induces IL-8 transcription. The ΔvscN1 and Δvp1680 strains induced similar levels of IL-8 transcription in the Caco-2 cells to the WT V. parahaemolyticus, while the ΔvscN2 strain induced a high level of IL-8 transcription (more than 4-fold the level of IL-8 transcript induced by the WT V. parahaemolyticus). This suggests that after 2 h of co-incubation TTSS1 is not involved in IL-8 mRNA production by the Caco-2 cells, while TTSS2 is involved in the inhibition of the IL-8 transcription.
The ELISA results show that 24 h after co-incubation, WT V. parahaemolyticus is a powerful activator of IL-8 secretion by Caco-2 cells, as there was a 15-fold increase in IL-8 concentrations after WT V. parahaemolyticus co-incubation in comparison to untreated Caco-2 cells (Figure 5C). Similar IL-8 concentrations were detected with the Caco-2 cells alone and in the presence of heat-killed WT V. parahaemolyticus. A dramatic reduction of IL-8 secretion was observed in response to ΔvscN1, showing an involvement of the TTSS1 apparatus in the activation of IL-8 secretion. Moreover, the use of the Δvp1680 strain showed an intermediate level of IL-8 secretion when compared to the WT and ΔvscN1 strains, suggesting that the effector protein VP1680 is involved in the IL-8 secretion activation by the Caco-2 cells in response to the bacteria but it is not the only TTSS1 effector responsible for this activation. With the ΔvscN2 strain there was a higher level of IL-8 secretion by the Caco-2 cells than that observed with the WT V. parahaemolyticus, suggesting that TTSS2 is involved in the inhibition of the IL-8 secretion by the Caco-2 cells in response to the bacteria 24 h after the addition of the bacteria.
These results demonstrate that V. parahaemolyticus actively induces the transcription and production of IL-8 by the host cell. TTSS1 is involved in the activation of IL-8 production by the host while TTSS2 is involved in its inhibition. Moreover, we have demonstrated that the TTSS1 effector VP1680 is involved in the stimulation of IL-8 secretion by the host.
The ERK signalling pathway is activated by V. parahaemolyticus and leads to IL-8 secretion by intestinal epithelial cells
In order to obtain a better overview of the signalling pathways leading to IL-8 activation in response to V. parahaemolyticus, the pharmacologic inhibitors of the MAPK signalling pathways were added during co-incubation and IL-8 secretion was quantified by ELISA (Figure 6). Addition of the inhibitors SB203580 and SP600125 had no influence on the level of IL-8 secreted by the Caco-2 cells co-incubated with WT V. parahaemolyticus, while the use of the ERK inhibitor PD98059 led to a significant decrease in the concentration of secreted IL-8. In fact a decrease of about 25% was seen in the IL-8 level secreted by the Caco-2 cells co-incubated with the WT V. parahaemolyticus when the cells have been pre-treated with PD98059. This result suggests that the inhibition of ERK signalling leads to inhibition of the resulting IL-8 secretion level. ERK signalling is a major signalling pathway activated by the WT V. parahaemolyticus and leads to the activation of IL-8 secretion by the eukaryotic cells.
The results of this study demonstrate that V. parahaemolyticus causes activation of MAPK in human intestinal epithelial cells and that this activation is linked to the cellular responses elicited by this bacterium. V. parahaemolyticus induced activation of each of the MAPK - JNK, p38 and ERK - in Caco-2 and HeLa cells (Figure 1 and 2). A mutant strain with a non-functional TTSS1 (ΔvscN 1) did not cause MAPK activation, providing the first evidence that TTSS1 is responsible for the activation of MAPK in epithelial cells in response to infection with V. parahaemolyticus (Figure 2). While the role of TTSS1 in ERK activation was difficult to observe in Caco-2 cells, differences in the activation of ERK in HeLa cells co-incubated with WT compared to ΔvscN 1 bacteria were clearly evident. V. parahaemolyticus therefore now joins a select group of gram-negative pathogens that use TTSS effectors to activate MAPK signalling to promote pathogen infection. Given the important role MAPK play in controlling host innate immune responses and cell growth, differentiation and death, they are commendable targets for pathogenic effectors. While several pathogens use their TTSS to inhibit MAPK activation [34, 35, 42, 43], others activate them. For example, the inflammatory responses induced by the TTSS effectors of Salmonella typhimurium are related to activation of all MAPK, especially p38 which induces IL-8 secretion from epithelial cells , and Burkholderia pseudomallei utilizes its TTSS to induce IL-8 secretion and to increase bacterial internalization via activation of p38 and JNK in epithelial cells .
Several Vibrio s pp. manipulate MAPK signalling pathways to induce host cell death or disturb the host response to infection [40, 45–49]. Vibrio vulnificus triggers phosphorylation of p38 and ERK via Reactive Oxygen Species in peripheral blood mononuclear cells thereby inducing host cell death . The CtxB cholera toxin from Vibrio cholerae down-regulates p38 and JNK activation in macrophages leading to suppression of production of TNFα and other pro-inflammatory cytokines [40, 47]. Additionally Flagellin A from V. cholerae contributes to IL-8 secretion from epithelial cells through TLR5 and activation of p38, ERK and JNK . Despite the fact that V. parahaemolyticus possesses flagellin proteins similar to those of V. cholerae, cells co-incubated with heat-killed V. parahaemolyticus did not exhibit MAPK phosphorylation (Figure 1), suggesting an absence of TLR5 recognition of flagellin. TLR5 is activated by dissociated flagellin monomers and the sheathed Vibrio flagella present on intact bacteria have a limited ability to trigger host innate immunity . In our studies bacteria were washed before addition to the cells and were treated at a temperature unlikely to dissociate flagellin monomers , thereby minimising the amounts of flagellin monomers present to trigger TLR5.
The results obtained from LDH assays, MTT assays and fluorochrome staining confirmed that the TTSS1 of V. parahaemolyticus is essential for the cytotoxicity of this bacterium towards epithelial cells (Figure 3). Furthermore these results show that there was no cell death detected prior to the 2 h time point, by which time MAPK activation was observed. It has been reported that undifferentiated Caco-2 cells are more susceptible than other cell types (e.g. HeLa cells) to a TTSS2-mediated delayed cytotoxicity [15, 51]. While TTSS1 was required for cytotoxicity during the first 4 h of co-incubation, there was little difference in the levels of cytotoxicity observed with ΔTTSS1 bacteria compared to WT V. parahaemolyticus when co-incubations were performed for 6 h . This delayed cell death was attributed to the VopT TTSS2 effector . Delayed cytotoxicity was also observed by Burdette et al. in HeLa cells infected with ΔTTSS2/Δvp1680 bacteria . The mechanism of this delayed cytotoxicity is unknown. With extended co-incubations of 8 h we too saw delayed TTSS1- and VP1680-independent cytotoxicity with differentiated Caco-2 cells (unpublished data Finn and Boyd). The delayed cytotoxicity was the not the subject of this study.
The VP1680 effector protein is responsible for the TTSS1-dependent autophagic cytotoxicity against HeLa cells [25, 29]. Our results demonstrated that VP1680 is required for the induction of JNK and p38 phosphorylation in Caco-2 cells (Figure 2) and that JNK and ERK, but not p38, are involved in the TTSS1-dependent cytotoxicity (Figure 4). Each of the 3 MAPK has been proposed to regulate autophagy and/or autophagic cell death, though the role and relative importance of each one seems to be dependent on cell type and on the induction stimulus [52–54]. The activation of JNK and ERK by VP1680 seems to be important for the cytotoxicity of V. parahaemolyticus towards epithelial cells, whereas phosphorylation of p38 by this effector protein plays a different role in modification of host cell behaviour that remains to be defined. In HeLa cells VP1680 is responsible for the activation of ERK, but plays a lesser role in the activation of JNK and p38 than it does in Caco-2 cells (Figure 2). As activation of all three MAPK in HeLa cells in response to V. parahaemolyticus is TTSS1-dependent, but not VP1680-dependent, this points to the existence of an additional MAPK-activating TTSS1 effector that acts in this cell line. Since VP1680 is the principal TTSS1 effector activating MAPK in Caco-2 cells, this would suggest differing sensitivities of cell lines to the TTSS effectors.
The observation that VP1680 induces phosphorylation of all 3 MAPK raises the possibility that this protein may not target the MAPK directly, but may trigger an upstream kinase. In contrast to VP1680, the VopA TTSS2 effector has been found to inhibit MAPK in macrophages by acetylating the upstream MAPK Kinase (MKK) [18, 30]. It is important to note that the VopA studies were performed with transfected eukaryotic cells that expressed VopA heterologously, whereas the current study assessed MAPK activation by intact V. parahaemolyticus. From our studies during co-incubation of V. parahaemolyticus with Caco-2 cells it appears that the MAPK activation of VP1680 is dominant over the inhibitory effect of VopA. V. parahaemolyticus may co-ordinately regulate both TTSS to achieve appropriate control of host responses.
V. parahaemolyticus induced IL-8 secretion in an active manner as a result of delivery of the TTSS effector proteins into host cells (Figure 5). It appears that there may be a balance between TTSS1 and TTSS2 of V. parahaemolyticus where TTSS1 is involved in the activation of IL-8 production by the host while TTSS2 is involved in its inhibition. This correlates with the opposing functions of the TTSS1 effector VP1680 and the TTSS2 effector VopA in activating and inhibiting MAPK phosphorylation. Interestingly, the TTSS1 effector VP1680 mutant (Δvp1680) induced intermediate amounts of IL-8, suggesting an involvement of this protein in stimulating production of this chemokine, but not an absolute requirement (Figure 5). Similarly the inhibitory studies revealed that V. parahaemolyticus induces secretion of IL-8 partly via modulation of the ERK signalling pathway (Figure 6). The complex effect of both TTSS of V. parahaemolyticus on the host immune defence machinery illustrates the powerful tools the bacteria possess to gain maximum advantage from the host environment.
A better understanding of the virulence mechanisms of V. parahaemolyticus is imperative for better diagnosis, treatment and prevention of gastrointestinal infections. The findings presented here provide new insights into the roles of TTSS1 and TTSS2 in modulating epithelial cell responses to infection. V. parahaemolyticus induced JNK, ERK and p38 activation in human epithelial cells. TTSS1, and the TTSS1 effector VP1680, were of key importance for sabotaging normal MAPK cellular processes and disrupting host responses to infection. MAPK activation was associated with the cytotoxic effects exerted by the bacterium and with the induction of IL-8 secretion. The diverse roles of MAPK signalling during infection with V. parahaemolyticus indicate it is a significant mechanism to promote virulence.
Cells and reagents
V. parahaemolyticus RIMD2210633, O3:K6 serotype (wild type, WT)  was used for the construction of deletion mutants as well as to perform all experiments. The following bacterial mutants were used: VVN1 (ΔTTSS1 with non-functional TTSS1 due to deletion in the vscN1 gene encoding the ATPase for TTSS1), VVN2 (ΔTTSS2 with non-functional TTSS2 due to deletion in the vscN2 gene encoding the ATPase for TTSS2) and VVE1 (Δvp1680). Bacteria were cultured at 37°C in Luria-Bertani medium supplemented with 3% (w/v) NaCl (LBN) and the addition of 1.5% (w/v) agar where appropriate. The human epithelial intestinal Caco-2 and cervical HeLa cell lines were obtained from the DSMZ (German Collection of Microorganisms and Cell Cultures). Caco-2 cells were grown as a monolayer in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 2 mM L-glutamine (Gibco), Pen-Strep (100 units/ml penicillin, 100 μg/ml streptomycin, (Gibco), 1% non-essential amino acids (Gibco) and 20% (v/v) Foetal Bovine Serum (Gibco) at 37°C, 5% CO2. All materials used were purchased from Sigma, unless otherwise stated. Measurement of absorbance of samples in 96-well plates was performed using a Tecan Sunrise and Magellan software.
Construction of deletion mutant strains
Molecular biology techniques were performed according to Sambrook and Russell . PCR reagents were obtained from Bioline, DNA purification kits and molecular biology enzymes from Promega and oligonucleotides from MWG/Eurofins. The standard PCR reaction volume was 50 μl, containing 50 ng template DNA, 400 nM each primer and 1× Polymerase Mix (Bioline). 1st round PCR reactions in the overlap extension method were performed with Accuzyme polymerase and the standard PCR conditions were 3 min at 95°C (1 cycle), 30 sec at 95°C, 30 sec at 58°C, 2 min/kb at 68°C (30 cycles), 5 min at 68°C (1 cycle). Other PCR reactions were performed with Taq polymerase, and an extension time and temperature of 30 sec/kb and 72°C, respectively. In some cases the annealing temperature was optimised for a specific PCR reaction.
In-frame deletion mutations were constructed in the vscN g enes of each of the V. parahaemolyticus TTSS in order to inactivate each of these secretion systems independently. As the vscN gene encodes the ATPase that powers the secretion process, mutation of this gene eliminates secretion. The TTSS1-associated VscN1 is encoded by vp1668 and TTSS2-associated VscN2 is encoded by vpa1338. Each mutant allele was constructed by overlap PCR. The primers PrAB49 (AACGCGAACGCCACCGTC), PrAB50 (TCTGCTACGCGCTGCTTGAGC), PrAB51 (ACTTGCAGACAACTCTCCAACGCGTAC) and PrAB52 (GGAGAGTTGTCTGCAAGTCGAGTGATG) were used for generation of the vscN1Δ142-1065 allele encoding VscN1Δ51-355. Primers PrAB45 (GCCATCAGGTCAAGTGCAAG), PrAB47 (TCTATAGCTATTTCACCGCGGATTCTC), PrAB48 (CGGTGAAATAGCTATAGAACGCTACCC) and PrAB59 (GTCTACCGTATCTCGAATGAATAGCG) were employed to generate the vscN2Δ132-1154 allele encoding VscN2Δ45-385. The PCR products were cloned into pCR2.1 by TA topoisomerase cloning according to the manufacturer's instructions (Invitrogen). The alleles were then transferred into the suicide vector pDS132  by extraction with the restriction enzymes Sac I and Xba I, for vscN1 and vscN2 respectively, followed by ligation into the corresponding restriction sites of pDS132. This resulted in plasmid pABGA11 containing the vscN1Δ142-1065 allele and pABGA13 containing the vscN2Δ132-1154 allele.
Triparental conjugations with Escherichia coli CC118λpir(pEVS104)  were performed to introduce pABGA11 and pABGA13 into V. parahaemolyticus RIMD2210633 and selection of first recombinants was performed on LBN agar containing 5 μg/ml chloramphenicol. Subsequently second recombinants were selected on LBN agar containing 10% sucrose and then screened by PCR with primers PrAB49 and PrAB50 for vscN1 and primers PrAB45 and PrAB59 for vscN2. Bacteria that contained the gene of the expected shortened length were designated VVN1 for the vscn1 mutant strain and VVN2 for the vscn2 mutant strain.
V. parahaemolyticus VVE1 containing a mutated vp1680 gene was constructed in a similar manner utilising primers PrAB88 (AAACATGGCACTGTAAGCGTCG), PrAB89 (GGTTAGCGCACTCAAGCAAATGCTTGGC), PrAB91 (GCGCGTAAGAGGCTTAGAGC) and PrAB92 (GCTTGAGTGCGCT AACCTAAGCAAACTTG) to remove nucleotides 161-1120. In addition a TAA stop codon was introduced at codon 51 (altered nucleotide shown in italics) so that a truncated protein would be produced.
V. parahaemolyticus and epithelial cell line co-incubation studies
All experiments with Caco-2 cells were carried out on differentiated cells obtained by culturing of the cells for 7 days (3 days post-confluency). HeLa cells were seeded the day prior to the co-incubation. During co-incubations with bacteria the cells were maintained in growth medium free of Pen-Strep antibiotics. Bacteria were cultured to obtain cells in mid-log phase of growth and then washed with PBS. Monolayers were co-incubated with WT V. parahaemolyticus and constructed deletion mutants at an MOI of 10. After the co-incubation period samples were taken for analysis. Preliminary experiments were performed with a range of MOI. Cells infected with an MOI of 10 displayed reproducible and reliable MAPK activation and cell lysis data and so this MOI was selected for use throughout these studies. In some experiments MAPK inhibitors were added to the cells 2 h prior to the addition of the bacteria at these concentrations: 15 μM SP600125, 5 μM SB203580 and 40 μM PD184352.
Lactate Dehydrogenase (LDH) assay
The Caco-2 cells were co-incubated with bacteria for 1, 2, 3 or 4 h. The LDH assay was performed using the CytoTox 96 Non-Radioactive Cytotoxicity Assay kit (Promega) according to the manufacturer's instructions. The results obtained were analyzed using the formulas provided by manufacturer and expressed as percentage cell lysis.
MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay
The Caco-2 cells were co-incubated with bacteria for 1, 2, 3 or 4 h. The cells were washed and resuspended first in fresh complete medium containing 50 μg/ml gentamicin for 1 h and then 5 μg/ml gentamicin for 20 h to kill extracellular bacteria. Monolayers were then incubated in MTT solution (5 mg/ml; 50 μl/well) for a further 3 h. The medium containing MTT was removed and the insoluble violet formazan crystals were dissolved in dimethyl sulfoxide. The absorbance was measured at λ550-590 nm. Cell viability was calculated as a percentage of the untreated Caco-2 cells.
Phase contrast light microscopy and fluorescent microscopy
The Caco-2 cells were co-incubated with bacteria for 2 and 4 h. After the co-incubation monolayers were washed and imaged by phase contrast light microscopy on a Leica DM IL inverted microscope fitted with a DFC420C digital camera using LAS software. For fluorescent microscopy after the co-incubation periods all detached and adherent Caco-2 cells were harvested, washed and stained with 230 μM propidium iodide/300 μM Hoechst 33342 for 5-10 min. Three hundred Caco-2 cells were analyzed and scored under the Olympus fluorescent microscope IX51 using Cell software and the DAPI filter (λ488 nm, Hoechst 33342 and PI positive) and the TxRed filter (λ520 nm, PI positive only).
Following co-incubation with bacteria the epithelial cells were washed in PBS and lysed with Laemmli sample buffer. Samples were resolved on Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE) and transferred to nitrocellulose. The membranes were incubated first with the following primary rabbit antibodies - phospho-SAPK/JNK (Thr183/Tyr185) mAb, phospho-p42/44(Thr202/Thr204) pAb, phospho-p38 (Thr180/Tyr182) pAb obtained from Cell Signalling Technology Inc - and then with Horse Radish Peroxidase (HRP)-conjugated anti-rabbit IgG antibody (Jackson ImmunoReseach Laboratories). Blots were developed using the enhanced chemiluminescence detection method. Non-saturated film exposures were digitized by flatbed scanning and quantified by densitometry. To detect total level of protein the membrane was re-probed with corresponding primary antibody: pan-JNK, p38 or p42/44 mouse mAb (R&D Systems).
Cell-Based Monodansylcadaverine (MDC) Assay
Caco-2 cells were seeded 24 h prior to the addition of the chemical MAPK inhibitors. Following 2 h incubation, WT V. parahaemolyticus was added to each well for 3 h. The MDC assay was performed using the Autophagy/Cytotoxicity Dual Staining Kit (Cayman Chemical Company) according to the manufacturer's instructions. Incubation steps were carried out in the dark. All centrifuge steps were omitted. The results obtained were analyzed using a Leica DMI3000B microscope and Leica application suite V3.3.0 software.
After co-incubation of the differentiated Caco-2 monolayers with V. parahaemolyticus, or 20 ηg/ml IL-1β as a positive control, IL-8 in the growth medium was detected by ELISA using the Bender Medsystem human IL-8 ELISA Kit following the manufacturer's instructions. This detection of IL-8 was performed 6 h and 24 h after a 2 h co-incubation period which had been stopped by three successive washes with PBS and the addition of complete growth medium containing 50 μg/ml gentamicin.
RNA extraction and reverse transcription PCR
RNA was extracted by the Trizol method (Invitrogen). The RNA preparations were treated with DNAse I (Invitrogen) to remove contaminating DNA and reverse-transcribed by use of an M-MLV reverse transcriptase (Invitrogen). Then PCR was performed for 30 cycles at 95°C, 30 s; 55°C, 30 s; 72°C, 30 s with a final amplification for 5 min at 72°C. The IL-8 gene was amplified using the primers IL-8 Forward GTTCCACTGTGCCTTGGTTT and IL-8 Reverse ACACAGCTGGCAATGACAAG, and the β-actin gene as control was amplified using β-actin Forward AAATCTGGCACCACACCTTC and β-actin Reverse AGTGGGGTGGCTTTTAGGAT. Visualisation of the PCR products was performed following agarose gel electrophoresis using SYBRsafe (Invitrogen) and a UV light source on a G:Box from SynGene and using the software GeneSnap from Syngene. Quantification was performed by comparing the intensity of the PCR product bands to the Quantitative Hyperladder I (Bioline) as a reference and then determining the ratio between IL-8 and β- actin PCR products in each sample.
Significance of the differences between groups was assessed using one way analysis of variance (ANOVA) with post-hoc Tukey-Kramer multiple comparisons test using GraphPad Instat software. p < 0.05 were considered statistically significant.
Krantz GE, Colwell RR, Lovelace E: Vibrio parahaemolyticus from the blue crab Callinectes sapidus in Chesapeake Bay. Science. 1969, 164 (885): 1286-1287. 10.1126/science.164.3885.1286.
Kaneko T, Colwell RR: Ecology of Vibrio parahaemolyticus in Chesapeake Bay. J Bacteriol. 1973, 113 (1): 24-32.
Nair GB, Ramamurthy T, Bhattacharya SK, Dutta B, Takeda Y, Sack DA: Global dissemination of Vibrio parahaemolyticus serotype O3:K6 and its serovariants. Clin Microbiol Rev. 2007, 20 (1): 39-48. 10.1128/CMR.00025-06.
Boyd EF, Cohen AL, Naughton LM, Ussery DW, Binnewies TT, Stine OC, Parent MA: Molecular analysis of the emergence of pandemic Vibrio parahaemolyticus. BMC Microbiol. 2008, 8: 110-10.1186/1471-2180-8-110.
Chowdhury A, Ishibashi M, Thiem VD, Tuyet DT, Tung TV, Chien BT, Seidlein Lv L, Canh DG, Clemens J, Trach DD, et al: Emergence and serovar transition of Vibrio parahaemolyticus pandemic strains isolated during a diarrhea outbreak in Vietnam between 1997 and 1999. Microbiol Immunol. 2004, 48 (4): 319-327.
Martinez-Urtaza J, Simental L, Velasco D, DePaola A, Ishibashi M, Nakaguchi Y, Nishibuchi M, Carrera-Flores D, Rey-Alvarez C, Pousa A: Pandemic Vibrio parahaemolyticus O3:K6, Europe. Emerg Infect Dis. 2005, 11 (8): 1319-1320.
Okuda J, Ishibashi M, Hayakawa E, Nishino T, Takeda Y, Mukhopadhyay AK, Garg S, Bhattacharya SK, Nair GB, Nishibuchi M: Emergence of a unique O3:K6 clone of Vibrio parahaemolyticus in Calcutta, India, and isolation of strains from the same clonal group from Southeast Asian travelers arriving in Japan. J Clin Microbiol. 1997, 35 (12): 3150-3155.
Daniels NA, MacKinnon L, Bishop R, Altekruse S, Ray B, Hammond RM, Thompson S, Wilson S, Bean NH, Griffin PM, et al: Vibrio parahaemolyticus infections in the United States, 1973-1998. J Infect Dis. 2000, 181 (5): 1661-1666. 10.1086/315459.
Qadri F, Alam MS, Nishibuchi M, Rahman T, Alam NH, Chisti J, Kondo S, Sugiyama J, Bhuiyan NA, Mathan MM, et al: Adaptive and inflammatory immune responses in patients infected with strains of Vibrio parahaemolyticus. J Infect Dis. 2003, 187 (7): 1085-1096. 10.1086/368257.
Lynch T, Livingstone S, Buenaventura E, Lutter E, Fedwick J, Buret AG, Graham D, DeVinney R: Vibrio parahaemolyticus disruption of epithelial cell tight junctions occurs independently of toxin production. Infect Immun. 2005, 73 (3): 1275-1283. 10.1128/IAI.73.3.1275-1283.2005.
Takahashi A, Kenjyo N, Imura K, Myonsun Y, Honda T: Cl- secretion in colonic epithelial cells induced by the Vibrio parahaemolyticus hemolytic toxin related to thermostable direct hemolysin. Infect Immun. 2000, 68 (9): 5435-5438. 10.1128/IAI.68.9.5435-5438.2000.
Makino K, Oshima K, Kurokawa K, Yokoyama K, Uda T, Tagomori K, Iijima Y, Najima M, Nakano M, Yamashita A, et al: Genome sequence of Vibrio parahaemolyticus: a pathogenic mechanism distinct from that of V. cholerae. Lancet. 2003, 361 (9359): 743-749. 10.1016/S0140-6736(03)12659-1.
Park KS, Ono T, Rokuda M, Jang MH, Iida T, Honda T: Cytotoxicity and enterotoxicity of the thermostable direct hemolysin-deletion mutants of Vibrio parahaemolyticus. Microbiol Immunol. 2004, 48 (4): 313-318.
Park KS, Ono T, Rokuda M, Jang MH, Okada K, Iida T, Honda T: Functional characterization of two type III secretion systems of Vibrio parahaemolyticus. Infect Immun. 2004, 72 (11): 6659-6665. 10.1128/IAI.72.11.6659-6665.2004.
Hiyoshi H, Kodama T, Iida T, Honda T: Contribution of Vibrio parahaemolyticus virulence factors to cytotoxicity, enterotoxicity and mice lethality. Infect Immun. 2010, 78 (4): 1772-1780. 10.1128/IAI.01051-09.
Okada N, Iida T, Park KS, Goto N, Yasunaga T, Hiyoshi H, Matsuda S, Kodama T, Honda T: Identification and characterization of a novel type III secretion system in trh-positive Vibrio parahaemolyticus strain TH3996 reveal genetic lineage and diversity of pathogenic machinery beyond the species level. Infect Immun. 2009, 77 (2): 904-913. 10.1128/IAI.01184-08.
Cornelis GR: Type III secretion: a bacterial device for close combat with cells of their eukaryotic host. Philos Trans R Soc Lond B Biol Sci. 2000, 355 (1397): 681-693. 10.1098/rstb.2000.0608.
Trosky JE, Mukherjee S, Burdette DL, Roberts M, McCarter L, Siegel RM, Orth K: Inhibition of MAPK signaling pathways by VopA from Vibrio parahaemolyticus. J Biol Chem. 2004, 279 (50): 51953-51957. 10.1074/jbc.M407001200.
Johnson GL, Lapadat R: Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 2002, 298 (5600): 1911-1912. 10.1126/science.1072682.
Roux PP, Blenis J: ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev. 2004, 68 (2): 320-344. 10.1128/MMBR.68.2.320-344.2004.
Chang L, Karin M: Mammalian MAP kinase signalling cascades. Nature. 2001, 410 (6824): 37-40. 10.1038/35065000.
Shan L, He P, Sheen J: Intercepting host MAPK signaling cascades by bacterial type III effectors. Cell Host Microbe. 2007, 1 (3): 167-174. 10.1016/j.chom.2007.04.008.
Bhavsar AP, Guttman JA, Finlay BB: Manipulation of host-cell pathways by bacterial pathogens. Nature. 2007, 449 (7164): 827-834. 10.1038/nature06247.
Bliska JB: Yersinia inhibits host signaling by acetylating MAPK kinases. ACS Chem Biol. 2006, 1 (6): 349-351. 10.1021/cb600261k.
Ono T, Park KS, Ueta M, Iida T, Honda T: Identification of proteins secreted via Vibrio parahaemolyticus type III secretion system 1. Infect Immun. 2006, 74 (2): 1032-1042. 10.1128/IAI.74.2.1032-1042.2006.
Burdette DL, Yarbrough ML, Orvedahl A, Gilpin CJ, Orth K: Vibrio parahaemolyticus orchestrates a multifaceted host cell infection by induction of autophagy, cell rounding, and then cell lysis. Proc Natl Acad Sci USA. 2008, 105 (34): 12497-12502. 10.1073/pnas.0802773105.
Bhattacharjee RN, Park KS, Okada K, Kumagai Y, Uematsu S, Takeuchi O, Akira S, Iida T, Honda T: Microarray analysis identifies apoptosis regulatory gene expression in HCT116 cells infected with thermostable direct hemolysin-deletion mutant of Vibrio parahaemolyticus. Biochem Biophys Res Commun. 2005, 335 (2): 328-334. 10.1016/j.bbrc.2005.07.080.
Zhou X, Konkel ME, Call DR: Type III secretion system 1 of Vibrio parahaemolyticus induces oncosis in both epithelial and monocytic cell lines. Microbiology. 2009, 155 (3): 837-851. 10.1099/mic.0.024919-0.
Burdette DL, Seemann J, Orth K: Vibrio VopQ induces PI3-kinase-independent autophagy and antagonizes phagocytosis. Mol Microbiol. 2009, 73 (4): 639-649. 10.1111/j.1365-2958.2009.06798.x.
Trosky JE, Li Y, Mukherjee S, Keitany G, Ball H, Orth K: VopA inhibits ATP binding by acetylating the catalytic loop of MAPK kinases. J Biol Chem. 2007, 282 (47): 34299-34305. 10.1074/jbc.M706970200.
Eckmann L, Kagnoff MF, Fierer J: Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect Immun. 1993, 61 (11): 4569-4574.
Fierer J, Eckmann L, Kagnoff M: IL-8 secreted by epithelial cells invaded by bacteria. Infect Agents Dis. 1993, 2 (4): 255-258.
Liu Y, Shepherd EG, Nelin LD: MAPK phosphatases - regulating the immune response. Nat Rev Immunol. 2007, 7 (3): 202-212. 10.1038/nri2035.
Li H, Xu H, Zhou Y, Zhang J, Long C, Li S, Chen S, Zhou JM, Shao F: The phosphothreonine lyase activity of a bacterial type III effector family. Science. 2007, 315 (5814): 1000-1003. 10.1126/science.1138960.
Lin SL, Le TX, Cowen DS: SptP, a Salmonella typhimurium type III-secreted protein, inhibits the mitogen-activated protein kinase pathway by inhibiting Raf activation. Cell Microbiol. 2003, 5 (4): 267-275. 10.1046/j.1462-5822.2003.t01-1-00274.x.
Orth K, Xu Z, Mudgett MB, Bao ZQ, Palmer LE, Bliska JB, Mangel WF, Staskawicz B, Dixon JE: Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease. Science. 2000, 290 (5496): 1594-1597. 10.1126/science.290.5496.1594.
Yarbrough ML, Li Y, Kinch LN, Grishin NV, Ball HL, Orth K: AMPylation of Rho GTPases by Vibrio VopS disrupts effector binding and downstream signaling. Science. 2009, 323 (5911): 269-272. 10.1126/science.1166382.
Bhattacharjee RN, Park KS, Chen X, Iida T, Honda T, Takeuchi O, Akira S: Translocation of VP1686 upregulates RhoB and accelerates phagocytic activity of macrophage through actin remodeling. J Microbiol Biotechnol. 2008, 18 (1): 171-175.
Hobbie S, Chen LM, Davis RJ, Galan JE: Involvement of mitogen-activated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal epithelial cells. J Immunol. 1997, 159 (11): 5550-5559.
Satchell KJ: Activation and suppression of the proinflammatory immune response by Vibrio cholerae toxins. Microbes Infect. 2003, 5 (13): 1241-1247. 10.1016/j.micinf.2003.08.007.
Yu Y, Zeng H, Lyons S, Carlson A, Merlin D, Neish AS, Gewirtz AT: TLR5-mediated activation of p38 MAPK regulates epithelial IL-8 expression via posttranscriptional mechanism. Am J Physiol Gastrointest Liver Physiol. 2003, 285 (2): G282-290.
Reissinger A, Skinner JA, Yuk MH: Downregulation of mitogen-activated protein kinases by the Bordetella bronchiseptica Type III secretion system leads to attenuated nonclassical macrophage activation. Infect Immun. 2005, 73 (1): 308-316. 10.1128/IAI.73.1.308-316.2005.
Kramer RW, Slagowski NL, Eze NA, Giddings KS, Morrison MF, Siggers KA, Starnbach MN, Lesser CF: Yeast functional genomic screens lead to identification of a role for a bacterial effector in innate immunity regulation. PLoS Pathog. 2007, 3 (2): e21-10.1371/journal.ppat.0030021.
Hii CS, Sun GW, Goh JW, Lu J, Stevens MP, Gan YH: Interleukin-8 induction by Burkholderia pseudomallei can occur without Toll-like receptor signaling but requires a functional type III secretion system. J Infect Dis. 2008, 197 (11): 1537-1547. 10.1086/587905.
Kim WH, Goo SY, Shin MH, Chun SJ, Lee H, Lee KH, Park SJ: Vibrio vulnificus-induced death of Jurkat T-cells requires activation of p38 mitogen-activated protein kinase by NADPH oxidase-derived reactive oxygen species. Cell Immunol. 2008, 253 (1-2): 81-91. 10.1016/j.cellimm.2008.05.003.
Kim WH, Goo SY, Lee KH, Park SJ: Vibrio vulnificus-induced cell death of human mononuclear cells requires ROS-dependent activation of p38 and ERK 1/2 MAPKs. Immunol Invest. 2009, 38 (1): 31-48. 10.1080/08820130802500583.
Chen P, Li J, Barnes J, Kokkonen GC, Lee JC, Liu Y: Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. J Immunol. 2002, 169 (11): 6408-6416.
Harrison LM, Rallabhandi P, Michalski J, Zhou X, Steyert SR, Vogel SN, Kaper JB: Vibrio cholerae flagellins induce Toll-like receptor 5-mediated interleukin-8 production through mitogen-activated protein kinase and NF-kappaB activation. Infect Immun. 2008, 76 (12): 5524-5534. 10.1128/IAI.00843-08.
McCarter LL: Genetic and molecular characterization of the polar flagellum of Vibrio parahaemolyticus. J Bacteriol. 1995, 177 (6): 1595-1609.
Yoon SS, Mekalanos JJ: Decreased potency of the Vibrio cholerae sheathed flagellum to trigger host innate immunity. Infect Immun. 2008, 76 (3): 1282-1288. 10.1128/IAI.00736-07.
Kodama T, Rokuda M, Park KS, Cantarelli VV, Matsuda S, Iida T, Honda T: Identification and characterization of VopT, a novel ADP-ribosyltransferase effector protein secreted via the Vibrio parahaemolyticus type III secretion system 2. Cell Microbiol. 2007, 9 (11): 2598-2609. 10.1111/j.1462-5822.2007.00980.x.
Shimizu S, Konishi A, Nishida Y, Mizuta T, Nishina H, Yamamoto A, Tsujimoto Y: Involvement of JNK in the regulation of autophagic cell death. Oncogene. 2010, 29 (14): 2070-2082. 10.1038/onc.2009.487.
Webber JL, Tooze SA: Coordinated regulation of autophagy by p38alpha MAPK through mAtg9 and p38IP. EMBO J. 2009, 29 (1): 27-40. 10.1038/emboj.2009.321.
Goussetis DJ, Altman JK, Glaser H, McNeer JL, Tallman MS, Platanias LC: Autophagy is a critical mechanism for the induction of the antileukemic effects of arsenic trioxide. J Biol Chem. 2010, 285 (39): 29989-29997. 10.1074/jbc.M109.090530.
Sambrook J, Russell DW: Molecular cloning: a laboratory manual. 2001, Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press, 3
Philippe N, Alcaraz JP, Coursange E, Geiselmann J, Schneider D: Improvement of pCVD442, a suicide plasmid for gene allele exchange in bacteria. Plasmid. 2004, 51 (3): 246-255. 10.1016/j.plasmid.2004.02.003.
Stabb EV, Ruby EG: RP4-based plasmids for conjugation between Escherichia coli and members of the Vibrionaceae. Methods Enzymol. 2002, 358: 413-426. full_text.
We thank Prof Takeshi Honda (Osaka University, Japan) for providing V. parahaemolyticus RIMD2210633, Dr Dominique Schneider for providing plasmid pDS132 (Université Joseph Fourier, France) and Dr Eric Stabb (University of Georgia at Athens, USA) for providing E. coli CC118λpir(pEVS104). We thank Ann Smyth and Niamh McCormack for assistance in construction of mutants and Stephen Cunningham for assistance with the MDC assay. KMW and AM were funded by Marie Curie Transfer of Knowledge "GAMIDI" EU Transfer of Knowledge grant # MTKD-CT-2005-029774 and RF was funded by Science Foundation Ireland Research Frontiers Programme grant # 08-RFP-BIC1243. Some of the early studies for this work were funded by the National University of Ireland, Galway's Millennium Fund.
KMW carried out immunoblotting and cytotoxicity assays, participated in mutant construction and drafted the manuscript. RF carried out immunoblotting and cytotoxicity assays and participated in mutant construction. AM carried out the ELISA and RT-PCR experiments. COB participated in the design and coordination of the study. AWB participated in the design and coordination of the study. EC participated in the design and coordination of the study and hosted training visits of researchers. AB conceived of the study, participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
Ksenia Matlawska-Wasowska, Rebecca Finn contributed equally to this work.
Electronic supplementary material
Additional file 1:Figure S1: Morphological changes induced in Caco-2 cells by V. parahaemolyticus Δ vp1680. Caco-2 cells were co-incubated with V. parahaemolyticus WT, ΔvscN1, ΔvscN2 or Δvp1680 for 4 h. Morphological changes of the cells were then observed by phase contrast light microscope (magnification 400×). (PDF 948 KB)
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
Rights and permissions
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Matlawska-Wasowska, K., Finn, R., Mustel, A. et al. The Vibrio parahaemolyticus Type III Secretion Systems manipulate host cell MAPK for critical steps in pathogenesis. BMC Microbiol 10, 329 (2010). https://doi.org/10.1186/1471-2180-10-329
- Mitogen Activate Protein Kinase
- Mitogen Activate Protein Kinase Signalling
- Mitogen Activate Protein Kinase Activation
- Mitogen Activate Protein Kinase Inhibitor